annb0t
Top 20
MELBOURNEÂ and INDIANAPOLIS, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)Â is pleased to announce that Kevin Richardson, a senior global executive with a career focus on sales, marketing and business operations in the oncology and radiopharmaceutical markets, will commence in the role of CEO, Telix Americas, on 11 July 2022. (PRNewsfoto/Telix Pharmaceuticals Limited)
Kevin is an accomplished business leader with 25 years' experience in the healt...
>>> Read more: Kevin Richardson appointed as CEO, Telix Americas
Kevin is an accomplished business leader with 25 years' experience in the healt...
>>> Read more: Kevin Richardson appointed as CEO, Telix Americas
